My research interests surround the discovery of new antibiotics and identifying the exact mechanism by which those antibiotics kill bacteria. Finding new “mechanisms of action” reveals new drug targets that can be exploited in the battle against antimicrobial resistance (AMR). AMR accounts for around 700,000 deaths per annum globally and that number is predicted to rise to 10 million by 2050. The current economic burden of AMR is estimated to be at least €1.5 billion per year in the EU. New antibiotics and an improved understanding of how to use them will help to slow the progression of AMR, saving countless lives in the future.